Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 73.73 0.48 (0.66%) | NSE 73.61 0.29 (0.40%) | Trade | Add

BSE Live

Jan 01, 13:44

73.73 0.48 (0.66%)

Volume

AVERAGE VOLUME

5-Day

4,294

10-Day

2,321

30-Day

1,815

Prev. Close

73.25
Open Price

72.11

Bid Price (Qty.)
72.37 (213)
Offer Price (Qty.)
73.77 (126)

NSE Live

Jan 01, 13:43

73.61 0.29 (0.40%)

Volume

AVERAGE VOLUME

5-Day

9,390

10-Day

6,714

30-Day

8,270

1,155

Prev. Close

73.32
Open Price

71.50

Bid Price (Qty.)
73.00 (4)
Offer Price (Qty.)
73.61 (70)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	15.92	15.80	15.69	14.82	14.82
Total Share Capital	15.92	15.80	15.69	14.82	14.82
Reserves and Surplus	82.90	89.78	78.95	71.56	63.56
Total Reserves and Surplus	82.90	89.78	78.95	71.56	63.56
Total Shareholders Funds	98.82	105.58	96.03	87.32	79.32
NON-CURRENT LIABILITIES
Long Term Borrowings	31.40	36.35	30.52	27.01	23.93
Deferred Tax Liabilities [Net]	0.00	3.94	2.86	2.47	4.40
Other Long Term Liabilities	1.28	1.34	1.23	3.63	3.04
Long Term Provisions	5.60	4.93	4.91	4.60	3.97
Total Non-Current Liabilities	38.28	46.56	39.52	37.72	35.35
CURRENT LIABILITIES
Short Term Borrowings	113.21	97.48	94.71	70.99	75.05
Trade Payables	81.85	89.84	90.77	71.93	48.56
Other Current Liabilities	17.24	20.90	26.05	20.99	22.62
Short Term Provisions	1.16	0.93	0.63	0.67	0.65
Total Current Liabilities	213.46	209.16	212.15	164.57	146.87
Total Capital And Liabilities	350.56	361.30	347.70	289.61	261.54
ASSETS
NON-CURRENT ASSETS
Tangible Assets	70.95	53.18	52.62	44.92	45.42
Intangible Assets	15.82	11.38	10.45	7.98	7.23
Capital Work-In-Progress	2.79	0.47	0.00	1.16	0.00
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	89.56	65.03	63.07	54.06	52.65
Non-Current Investments	2.16	9.58	8.40	8.40	8.40
Deferred Tax Assets [Net]	0.40	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.33
Other Non-Current Assets	10.80	5.55	6.29	6.89	6.96
Total Non-Current Assets	102.91	80.16	77.75	69.35	68.34
CURRENT ASSETS
Current Investments	2.47	6.76	0.00	0.00	0.00
Inventories	102.78	87.49	97.69	73.97	60.12
Trade Receivables	94.85	103.10	94.84	77.91	69.44
Cash And Cash Equivalents	7.94	13.13	7.35	5.09	3.72
Short Term Loans And Advances	1.13	35.12	33.66	25.72	20.70
OtherCurrentAssets	38.49	35.54	36.41	37.57	39.23
Total Current Assets	247.65	281.14	269.95	220.27	193.20
Total Assets	350.56	361.30	347.70	289.61	261.54
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	17.10	16.96	16.44	16.25	4.34
CIF VALUE OF IMPORTS
Raw Materials	58.88	0.07	68.25	74.94	56.77
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	6.26	5.22	3.32	1.63	1.85
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	165.18	194.97	202.03	183.60	150.43
Other Earnings	--	--	--	--	--
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	0.11	--	--	--
Non-Current Investments Unquoted Book Value	2.16	9.59	--	--	9.57
CURRENT INVESTMENTS
Current Investments Quoted Market Value	2.47	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--